Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,293 papers from all fields of science
Search
Sign In
Create Free Account
Treatment related secondary malignancy
Known as:
Cancers, Therapy-Related
, Cancer, Treatment-Related
, Cancers, Treatment-Associated
Expand
The development of a malignant neoplasm in response to medical or surgical treatment, induced by the treatment itself.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (1)
Neoplasms, Second Primary
Neoplastic Cell
Second Primary Cancers
cancer cell
Narrower (1)
Secondary Malignant Neoplasm
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Vaccination with Predesignated or Evidence-Based Peptides for Patients with Recurrent Gynecologic Cancers
N. Tsuda
,
K. Mochizuki
,
+9 authors
T. Kamura
Journal of immunotherapy
2004
Corpus ID: 41337217
Two different trials of peptide vaccination were conducted for patients with recurrent gynecologic cancers. In the first regimen…
Expand
Highly Cited
2002
Highly Cited
2002
Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P‐glycoprotein‐expressing cells
A. Ruefli
,
D. Bernhard
,
K. Tainton
,
R. Kofler
,
M. Smyth
,
R. Johnstone
International Journal of Cancer
2002
Corpus ID: 23069291
Multidrug resistance (MDR) mediated by the ATP‐dependent efflux protein P‐glycoprotein (P‐gp) is a major obstacle to the…
Expand
Review
1999
Review
1999
Two models for radiological reviewing of interval cancers
K. Moberg
,
H. Grundström
,
+4 authors
C. Muren
Journal of Medical Screening
1999
Corpus ID: 24459487
Objectives To compare two different review methods of examining how many of our interval cancers could be regarded as missed…
Expand
1999
1999
Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy.
R. Ghavamian
,
M. Blute
,
E. Bergstralh
,
J. Slezak
,
H. Zincke
Urology
1999
Corpus ID: 23116935
1997
1997
The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer
J. Keen
,
J. Dixon
,
+5 authors
W. Miller
Breast Cancer Research and Treatment
1997
Corpus ID: 20567123
Ki-S1, a marker of proliferation, and bcl-2, thegene product of which is an antagonist ofapoptosis, have been measured in 51 ER…
Expand
Review
1984
Review
1984
T3 glottic cancer: Options and consequences of the options
L. Desanto
The Laryngoscope
1984
Corpus ID: 38418364
This report is a review of 106 Stage III glottic cancers treated surgically from January 1971 through December 1980. For analysis…
Expand
1979
1979
Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer
D. Tataryn
,
J. Macfarlane
,
David Murray
,
D. Thomson
Cancer
1979
Corpus ID: 26354349
Tumor‐specific immunity to carcinoma of the colon, pancreas and stomach was assayed by tube LAI. Cancers of the colon, pancreas…
Expand
1979
1979
The value of a sensitive assay of carcino‐placental alkaline phosphatase (CPAP) in the follow‐up of gynecological cancers
W. Haije
,
J. Meerwaldt
,
+5 authors
J. van Driel
International Journal of Cancer
1979
Corpus ID: 10163142
Using a sensitive enzyme immunoassay, carcinoplacental alkaline phosphatase (CPAP) was determined in sera of 1266 patients with…
Expand
1974
1974
Surgical management of irradiation failures of nonfixed cancers of the glottic region.
A. Ballantyne
,
G. Fletcher
The American journal of roentgenology, radium…
1974
Corpus ID: 12089450
Review
1971
Review
1971
Epidemiology of asbestos cancers.
J. Wagner
,
J. C. Gilson
,
G. Berry
,
V. Timbrell
British Medical Bulletin
1971
Corpus ID: 10604059
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE